Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Reexamination Certificate
2007-07-31
2007-07-31
Zeman, Robert A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
C530S350000
Reexamination Certificate
active
10510720
ABSTRACT:
The present invention relates to an anti-idiotype antibodies directed against the monoclonal antibody (HmenB3) toNeisseria meningitidisserogroup B and hybridomas producing the anti-idiotype antibodies. This invention is also directed to vaccine compositions comprising the anti-idiotypic antibodies in combination with pharmaceutically acceptable carriers. These vaccine compositions can be used to prevent or treat the serogroup B meningococcal disease.
REFERENCES:
patent: 6048527 (2000-04-01), Granoff et al.
patent: 6248329 (2001-06-01), Chandrashekar et al.
Greenspan et al. (Nature Biotechnology 17: 936-937, 1999).
Bowie et al (Science, 1990, 247:1306-1310).
Ellis (Chapter 29 of Vaccines, Plotkin, et al. (eds) WB Saunders, Philadelphia, 1988, pp. 568-575.
J. Finne et al., Lancet, Aug. 13, 1983, pp. 355-357.
P.F. Kohler et al., J. Clin. Invest., vol. 75, Mar. 1985, pp. 883-888.
D.W. Pascual et al., Journal of Immunological Methods, vol. 146, 1992, pp. 249-255.
B.D. Livingston et al., The Journal of Biological Chemistry, vol. 263, Jul. 6, 1988, pp. 9443-9448.
E. Rosenstein et al., N. Engl. J. Med., vol. 344, No. 18, May 3, 2001, pp. 1378-1388.
J. Parkhill et al., Nature, vol. 404, Mar. 30, 2000, pp. 502-506.
H. Tettelin et al., Science, vol. 287, Mar. 10, 2000, pp. 1809-1815.
D.A.A. Ala Aldeen et al., Journal of Infection, vol. 33, 1996, pp. 153-157.
F.X. Riedo et al., Pediatr. Infec. Dis. J., vol. 14, 1995, pp. 643-657.
J. Finne et al., The Journal of Immunology, vol. 138, No. 12, Jun. 15, 1987, pp. 4402-4407.
J. Nedelec et al., Journal of Neuroimmunology, vol. 29, 1990, pp. 49-56.
H.J. Jennings et al., J. Exp. Med., vol. 165, Apr. 1987, pp. 1207-1211.
D.M. Granoff et al., The Journal of Immunology, vol. 160, 1998, pp. 5028-5036.
R.A. Pon et al., J. Exp. Med., vol. 185, No. 11, Jun. 2, 1997, pp. 1929-1938.
M.A.J. Westerink et al., Proc. Natl. Acad. Sci. USA, vol. 92, Apr. 1995, pp. 4021-4025.
W. Magliani et al., Nat. Med., vol. 4, No. 6, Jun. 1998, pp. 705-709.
J.S. Shin et al., Infection and Immunity, vol. 69, No. 5, May 2001, pp. 3335-3342.
L.J. Harris et al., Biochemistry, vol. 36, 1997, pp. 1581-1597.
J.G. Augustine et al., The Journal of Biological Chemistry, vol. 276, No. 5, Feb. 2, 2001, pp. 3287-3294.
Y. Li et al., Biochemistry, vol. 39, 2000, pp. 6296-6309.
J. Finne et al., Biochemical and Biophysical Research Communications, vol. 112, No. 2, Apr. 29, 1983.
Choi In-Hong
Nahm Moon H.
Park In-Ho
Shin Jeon-Soo
Gangle Brian J.
Yonsei University
Zeman Robert A.
LandOfFree
Vaccine composition for preventing meningococcal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition for preventing meningococcal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition for preventing meningococcal disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3733933